var eventsData = [{"Ticker":"PCLN","EffectiveDate":"2017-01-20","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on PCLN to Buy. Target Price is $1950.","DailyReturn":0.003892,"FiveDayReturnAfter":0.027188,"FiveDayReturnBefore":0.001891},{"Ticker":"PCLN","EffectiveDate":"2017-01-19","Type":"RatingNeutral","Title":"MKM Partners initiates coverage on PCLN to Buy. Target Price is $145.","DailyReturn":-0.001842,"FiveDayReturnAfter":0.023686,"FiveDayReturnBefore":0.004295},{"Ticker":"PCLN","EffectiveDate":"2017-01-10","Type":"RatingNeutral","Title":"Citigroup initiates coverage on PCLN to Buy.","DailyReturn":0.003668,"FiveDayReturnAfter":0.006834,"FiveDayReturnBefore":0.042453},{"Ticker":"PCLN","EffectiveDate":"2017-01-04","Type":"RatingNeutral","Title":"Needham initiates coverage on PCLN to Buy. Target Price is $1800.","DailyReturn":0.006578,"FiveDayReturnAfter":0.038294,"FiveDayReturnBefore":-0.005825},{"Ticker":"PCLN","EffectiveDate":"2016-12-08","Type":"RatingNeutral","Title":"CLSA initiates coverage on PCLN to Buy. Target Price is $1900.","DailyReturn":0.014165,"FiveDayReturnAfter":0.000925,"FiveDayReturnBefore":0.015416},{"Ticker":"PCLN","EffectiveDate":"2016-11-10","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $1900; previously $1650.","DailyReturn":-0.010151,"FiveDayReturnAfter":-0.043625,"FiveDayReturnBefore":0.082903},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1776; previously $1560.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1790; previously $1750.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $1800; previously $1600.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1750; previously $1560.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Ascendiant Capital maintains PCLN to Buy. Target Price is $1700; previously $1600.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Pacific Crest maintains PCLN to Sector Weight.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1600; previously $1400.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1800; previously $1700.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"RBC Capital maintains PCLN to Outperform. Target Price is $1850; previously $1750.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"UBS maintains PCLN to Neutral. Target Price is $1600.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingNeutral","Title":"Wells Fargo maintains PCLN to Market Perform.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-08","Type":"RatingUpgrade","Title":"Barclays upgrades PCLN to Overweight. Target Price is $1750; previously $1550.","DailyReturn":0.066066,"FiveDayReturnAfter":0.00596,"FiveDayReturnBefore":0.004129},{"Ticker":"PCLN","EffectiveDate":"2016-11-07","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2016 Q3's earning $31.18 per share and revenue $3691MM. This beats analyst's estimated EPS $29.51, beats estimated revenue $3620MM.","DailyReturn":0.039353,"FiveDayReturnAfter":0.078537,"FiveDayReturnBefore":-0.034869},{"Ticker":"PCLN","EffectiveDate":"2016-11-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.039353,"FiveDayReturnAfter":0.078537,"FiveDayReturnBefore":-0.034869},{"Ticker":"PCLN","EffectiveDate":"2016-11-07","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.039353,"FiveDayReturnAfter":0.078537,"FiveDayReturnBefore":-0.034869},{"Ticker":"PCLN","EffectiveDate":"2016-10-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.004768,"FiveDayReturnAfter":-0.028954,"FiveDayReturnBefore":0.026765},{"Ticker":"PCLN","EffectiveDate":"2016-10-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.004768,"FiveDayReturnAfter":-0.028954,"FiveDayReturnBefore":0.026765},{"Ticker":"PCLN","EffectiveDate":"2016-09-08","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.00126,"FiveDayReturnAfter":-0.010184,"FiveDayReturnBefore":0.0192},{"Ticker":"PCLN","EffectiveDate":"2016-08-18","Type":"RatingUpgrade","Title":"Evercore ISI Group upgrades PCLN to Buy from Hold. Target Price is $1650; previously $1350.","DailyReturn":0.01112,"FiveDayReturnAfter":-0.011998,"FiveDayReturnBefore":0.014766},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"Barclays maintains PCLN to Overweight. Target Price is $1550; previously $1500.","DailyReturn":0.039875,"FiveDayReturnAfter":0.033927,"FiveDayReturnBefore":0.025236},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1400; previously $1250.","DailyReturn":0.039875,"FiveDayReturnAfter":0.033927,"FiveDayReturnBefore":0.025236},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Hold. Target Price is $1450; previously $1330.","DailyReturn":0.039875,"FiveDayReturnAfter":0.033927,"FiveDayReturnBefore":0.025236},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"UBS maintains PCLN to Buy. Target Price is $1600; previously $1475.","DailyReturn":0.039875,"FiveDayReturnAfter":0.033927,"FiveDayReturnBefore":0.025236},{"Ticker":"PCLN","EffectiveDate":"2016-08-05","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $1620; previously $1460.","DailyReturn":0.039875,"FiveDayReturnAfter":0.033927,"FiveDayReturnBefore":0.025236},{"Ticker":"PCLN","EffectiveDate":"2016-08-04","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.008132,"FiveDayReturnAfter":0.025307,"FiveDayReturnBefore":0.034623},{"Ticker":"PCLN","EffectiveDate":"2016-08-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.008132,"FiveDayReturnAfter":0.025307,"FiveDayReturnBefore":0.034623},{"Ticker":"PCLN","EffectiveDate":"2016-08-04","Type":"EarningsBeatRevenueMiss","Title":"After market close, PCLN reports 2016 Q2's earning $13.93 per share and revenue $2556MM. This beats analyst's estimated EPS $12.69, misses estimated revenue $2580MM.","DailyReturn":-0.008132,"FiveDayReturnAfter":0.025307,"FiveDayReturnBefore":0.034623},{"Ticker":"PCLN","EffectiveDate":"2016-08-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.008132,"FiveDayReturnAfter":0.025307,"FiveDayReturnBefore":0.034623},{"Ticker":"PCLN","EffectiveDate":"2016-06-30","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades PCLN to Overweight from Equal-Weight. Target Price is $1525; previously $1330.","DailyReturn":0.007262,"FiveDayReturnAfter":0.04562,"FiveDayReturnBefore":-0.092922},{"Ticker":"PCLN","EffectiveDate":"2016-06-22","Type":"RatingUpgrade","Title":"Barclays upgrades PCLN to Overweight from Equal-Weight. Target Price is $1500; previously $1300.","DailyReturn":0.012695,"FiveDayReturnAfter":-0.109086,"FiveDayReturnBefore":0.02943},{"Ticker":"PCLN","EffectiveDate":"2016-06-02","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.00939,"FiveDayReturnAfter":0.058379,"FiveDayReturnBefore":0.016863},{"Ticker":"PCLN","EffectiveDate":"2016-05-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.013383,"FiveDayReturnAfter":0.002295,"FiveDayReturnBefore":-0.000031},{"Ticker":"PCLN","EffectiveDate":"2016-05-19","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.013383,"FiveDayReturnAfter":0.002295,"FiveDayReturnBefore":-0.000031},{"Ticker":"PCLN","EffectiveDate":"2016-05-18","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.008411,"FiveDayReturnAfter":-0.016877,"FiveDayReturnBefore":0.007659},{"Ticker":"PCLN","EffectiveDate":"2016-05-18","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.008411,"FiveDayReturnAfter":-0.016877,"FiveDayReturnBefore":0.007659},{"Ticker":"PCLN","EffectiveDate":"2016-05-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.008411,"FiveDayReturnAfter":-0.016877,"FiveDayReturnBefore":0.007659},{"Ticker":"PCLN","EffectiveDate":"2016-05-13","Type":"RatingNeutral","Title":"Barclays maintains PCLN to Equal-Weight. Target Price is $1300; previously $1340.","DailyReturn":-0.002815,"FiveDayReturnAfter":-0.025224,"FiveDayReturnBefore":0.032819},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1420; previously $1500.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $1510.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Ascendiant Capital maintains PCLN to Buy. Target Price is $1600; previously $1625.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1660.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1525; previously $1550.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"RBC Capital maintains PCLN to Outperform. Target Price is $1600; previously $1700.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Oppenheimer maintains PCLN to Outperform. Target Price is $1420; previously $1460.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1580; previously $1600.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Neutral. Target Price is $1250.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-05","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Equal-Weight. Target Price is $1330.","DailyReturn":-0.009728,"FiveDayReturnAfter":0.011323,"FiveDayReturnBefore":-0.077299},{"Ticker":"PCLN","EffectiveDate":"2016-05-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.075001,"FiveDayReturnAfter":-0.065883,"FiveDayReturnBefore":0.015391},{"Ticker":"PCLN","EffectiveDate":"2016-05-04","Type":"RatingNeutral","Title":"Guggenheim downgrades PCLN to Neutral from Buy.","DailyReturn":-0.075001,"FiveDayReturnAfter":-0.065883,"FiveDayReturnBefore":0.015391},{"Ticker":"PCLN","EffectiveDate":"2016-05-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.075001,"FiveDayReturnAfter":-0.065883,"FiveDayReturnBefore":0.015391},{"Ticker":"PCLN","EffectiveDate":"2016-04-27","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.014836,"FiveDayReturnAfter":0.015391,"FiveDayReturnBefore":-0.008829},{"Ticker":"PCLN","EffectiveDate":"2016-04-27","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.014836,"FiveDayReturnAfter":0.015391,"FiveDayReturnBefore":-0.008829},{"Ticker":"PCLN","EffectiveDate":"2016-04-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.014836,"FiveDayReturnAfter":0.015391,"FiveDayReturnBefore":-0.008829},{"Ticker":"PCLN","EffectiveDate":"2016-04-15","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.00336,"FiveDayReturnAfter":0.002697,"FiveDayReturnBefore":0.045849},{"Ticker":"PCLN","EffectiveDate":"2016-03-31","Type":"RatingNeutral","Title":"Pacific Crest initiates coverage on PCLN to Sector Weight.","DailyReturn":-0.021313,"FiveDayReturnAfter":-0.018406,"FiveDayReturnBefore":-0.001805},{"Ticker":"PCLN","EffectiveDate":"2016-03-08","Type":"RatingNeutral","Title":"Moffett Nathanson initiates coverage on PCLN to Buy. Target Price is $1475.","DailyReturn":-0.006706,"FiveDayReturnAfter":0.026213,"FiveDayReturnBefore":0.020512},{"Ticker":"PCLN","EffectiveDate":"2016-03-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00409,"FiveDayReturnAfter":-0.007139,"FiveDayReturnBefore":0.030885},{"Ticker":"PCLN","EffectiveDate":"2016-03-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.00409,"FiveDayReturnAfter":-0.007139,"FiveDayReturnBefore":0.030885},{"Ticker":"PCLN","EffectiveDate":"2016-02-18","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Hold. Target Price is $1350; previously $1333.","DailyReturn":0.013265,"FiveDayReturnAfter":0.022922,"FiveDayReturnBefore":0.220274},{"Ticker":"PCLN","EffectiveDate":"2016-02-18","Type":"RatingNeutral","Title":"Oppenheimer maintains PCLN to Outperform. Target Price is $1460; previously $1300.","DailyReturn":0.013265,"FiveDayReturnAfter":0.022922,"FiveDayReturnBefore":0.220274},{"Ticker":"PCLN","EffectiveDate":"2016-02-17","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.112436,"FiveDayReturnAfter":0.127638,"FiveDayReturnBefore":0.131524},{"Ticker":"PCLN","EffectiveDate":"2016-02-17","Type":"EarningsRevenueBeat","Title":"Before market open, PCLN reports 2015 Q4's earning $12.63 per share and revenue $2000MM. This beats analyst's estimated EPS $11.84, beats estimated revenue $1960MM.","DailyReturn":0.112436,"FiveDayReturnAfter":0.127638,"FiveDayReturnBefore":0.131524},{"Ticker":"PCLN","EffectiveDate":"2016-02-17","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.112436,"FiveDayReturnAfter":0.127638,"FiveDayReturnBefore":0.131524},{"Ticker":"PCLN","EffectiveDate":"2016-01-27","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Hold. Target Price is $1333; previously $1475.","DailyReturn":-0.061033,"FiveDayReturnAfter":-0.041092,"FiveDayReturnBefore":0.015449},{"Ticker":"PCLN","EffectiveDate":"2016-01-27","Type":"RatingNeutral","Title":"Goldman Sachs downgrades PCLN to Neutral from Buy.","DailyReturn":-0.061033,"FiveDayReturnAfter":-0.041092,"FiveDayReturnBefore":0.015449},{"Ticker":"PCLN","EffectiveDate":"2016-01-25","Type":"RatingNeutral","Title":"Wells Fargo initiates coverage on PCLN to Market Perform.","DailyReturn":-0.018048,"FiveDayReturnAfter":-0.048693,"FiveDayReturnBefore":-0.00292},{"Ticker":"PCLN","EffectiveDate":"2016-01-05","Type":"RatingNeutral","Title":"Raymond James downgrades PCLN to Outperform from Strong Buy.","DailyReturn":-0.027847,"FiveDayReturnAfter":-0.091672,"FiveDayReturnBefore":-0.021998},{"Ticker":"PCLN","EffectiveDate":"2015-12-16","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.006482,"FiveDayReturnAfter":-0.035556,"FiveDayReturnBefore":0.015039},{"Ticker":"PCLN","EffectiveDate":"2015-12-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.006482,"FiveDayReturnAfter":-0.035556,"FiveDayReturnBefore":0.015039},{"Ticker":"PCLN","EffectiveDate":"2015-12-10","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.008888,"FiveDayReturnAfter":0.028411,"FiveDayReturnBefore":0.015211},{"Ticker":"PCLN","EffectiveDate":"2015-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.008888,"FiveDayReturnAfter":0.028411,"FiveDayReturnBefore":0.015211},{"Ticker":"PCLN","EffectiveDate":"2015-11-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.002429,"FiveDayReturnAfter":-0.031359,"FiveDayReturnBefore":-0.022597},{"Ticker":"PCLN","EffectiveDate":"2015-11-20","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.002429,"FiveDayReturnAfter":-0.031359,"FiveDayReturnBefore":-0.022597},{"Ticker":"PCLN","EffectiveDate":"2015-11-20","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.002429,"FiveDayReturnAfter":-0.031359,"FiveDayReturnBefore":-0.022597},{"Ticker":"PCLN","EffectiveDate":"2015-11-09","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades PCLN to Hold.","DailyReturn":-0.095696,"FiveDayReturnAfter":-0.110861,"FiveDayReturnBefore":-0.002988},{"Ticker":"PCLN","EffectiveDate":"2015-11-06","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.00871,"FiveDayReturnAfter":-0.107158,"FiveDayReturnBefore":0.025616},{"Ticker":"PCLN","EffectiveDate":"2015-11-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00871,"FiveDayReturnAfter":-0.107158,"FiveDayReturnBefore":0.025616},{"Ticker":"PCLN","EffectiveDate":"2015-11-05","Type":"RatingNeutral","Title":"Deutsche Bank downgrades PCLN to Hold from Buy.","DailyReturn":-0.004709,"FiveDayReturnAfter":-0.100099,"FiveDayReturnBefore":0.045268},{"Ticker":"PCLN","EffectiveDate":"2015-11-04","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.003181,"FiveDayReturnAfter":-0.101476,"FiveDayReturnBefore":0.042976},{"Ticker":"PCLN","EffectiveDate":"2015-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.003181,"FiveDayReturnAfter":-0.101476,"FiveDayReturnBefore":0.042976},{"Ticker":"PCLN","EffectiveDate":"2015-09-09","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.002874,"FiveDayReturnAfter":0.02955,"FiveDayReturnBefore":0.025117},{"Ticker":"PCLN","EffectiveDate":"2015-09-09","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.002874,"FiveDayReturnAfter":0.02955,"FiveDayReturnBefore":0.025117},{"Ticker":"PCLN","EffectiveDate":"2015-09-04","Type":"RatingNeutral","Title":"Redburn Partners initiates coverage on PCLN to Buy.","DailyReturn":0.003934,"FiveDayReturnAfter":0.03955,"FiveDayReturnBefore":-0.00934},{"Ticker":"PCLN","EffectiveDate":"2015-08-05","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.052352,"FiveDayReturnAfter":0.018427,"FiveDayReturnBefore":0.060932},{"Ticker":"PCLN","EffectiveDate":"2015-08-05","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.052352,"FiveDayReturnAfter":0.018427,"FiveDayReturnBefore":0.060932},{"Ticker":"PCLN","EffectiveDate":"2015-07-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00406,"FiveDayReturnAfter":-0.011852,"FiveDayReturnBefore":0.055339},{"Ticker":"PCLN","EffectiveDate":"2015-07-23","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":-0.00406,"FiveDayReturnAfter":-0.011852,"FiveDayReturnBefore":0.055339},{"Ticker":"PCLN","EffectiveDate":"2015-06-22","Type":"RatingNeutral","Title":"Deutsche Bank downgrades PCLN to Hold from Buy. Target Price is $1325; previously $1425.","DailyReturn":-0.006966,"FiveDayReturnAfter":-0.015273,"FiveDayReturnBefore":-0.013471},{"Ticker":"PCLN","EffectiveDate":"2015-06-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.013203,"FiveDayReturnAfter":-0.021324,"FiveDayReturnBefore":-0.006768},{"Ticker":"PCLN","EffectiveDate":"2015-06-19","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.013203,"FiveDayReturnAfter":-0.021324,"FiveDayReturnBefore":-0.006768},{"Ticker":"PCLN","EffectiveDate":"2015-06-19","Type":"Item_1.02","Title":"Termination of a Material Definitive Agreement\r\n","DailyReturn":-0.013203,"FiveDayReturnAfter":-0.021324,"FiveDayReturnBefore":-0.006768},{"Ticker":"PCLN","EffectiveDate":"2015-06-19","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.013203,"FiveDayReturnAfter":-0.021324,"FiveDayReturnBefore":-0.006768},{"Ticker":"PCLN","EffectiveDate":"2015-06-04","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.006677,"FiveDayReturnAfter":-0.011603,"FiveDayReturnBefore":-0.003386},{"Ticker":"PCLN","EffectiveDate":"2015-06-03","Type":"RatingNeutral","Title":"Barclays initiates coverage on PCLN to Equal-Weight. Target Price is $1200.","DailyReturn":-0.001931,"FiveDayReturnAfter":-0.027764,"FiveDayReturnBefore":0.000202},{"Ticker":"PCLN","EffectiveDate":"2015-05-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010525,"FiveDayReturnAfter":-0.035234,"FiveDayReturnBefore":0.008059},{"Ticker":"PCLN","EffectiveDate":"2015-05-26","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.010525,"FiveDayReturnAfter":-0.035234,"FiveDayReturnBefore":0.008059},{"Ticker":"PCLN","EffectiveDate":"2015-05-19","Type":"RatingNeutral","Title":"Guggenheim initiates coverage on PCLN to Neutral.","DailyReturn":-0.002613,"FiveDayReturnAfter":-0.017458,"FiveDayReturnBefore":0.02535},{"Ticker":"PCLN","EffectiveDate":"2015-05-07","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.040074,"FiveDayReturnAfter":-0.070794,"FiveDayReturnBefore":0.01245},{"Ticker":"PCLN","EffectiveDate":"2015-05-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.040074,"FiveDayReturnAfter":-0.070794,"FiveDayReturnBefore":0.01245},{"Ticker":"PCLN","EffectiveDate":"2015-04-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.002384,"FiveDayReturnAfter":0.050554,"FiveDayReturnBefore":-0.006968},{"Ticker":"PCLN","EffectiveDate":"2015-04-21","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.002384,"FiveDayReturnAfter":0.050554,"FiveDayReturnBefore":-0.006968},{"Ticker":"PCLN","EffectiveDate":"2015-04-21","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.002384,"FiveDayReturnAfter":0.050554,"FiveDayReturnBefore":-0.006968},{"Ticker":"PCLN","EffectiveDate":"2015-04-06","Type":"RatingNeutral","Title":"Argus Research initiates coverage on PCLN to Buy. Target Price is $1480.","DailyReturn":0.021173,"FiveDayReturnAfter":0.024734,"FiveDayReturnBefore":0.017456},{"Ticker":"PCLN","EffectiveDate":"2015-03-31","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $1400.","DailyReturn":0.012454,"FiveDayReturnAfter":0.030112,"FiveDayReturnBefore":-0.026899},{"Ticker":"PCLN","EffectiveDate":"2015-03-18","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $1352; previously $1375.","DailyReturn":0.024376,"FiveDayReturnAfter":0.013905,"FiveDayReturnBefore":-0.032007},{"Ticker":"PCLN","EffectiveDate":"2015-03-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.024376,"FiveDayReturnAfter":0.013905,"FiveDayReturnBefore":-0.032007},{"Ticker":"PCLN","EffectiveDate":"2015-03-18","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.024376,"FiveDayReturnAfter":0.013905,"FiveDayReturnBefore":-0.032007},{"Ticker":"PCLN","EffectiveDate":"2015-03-13","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.024296,"FiveDayReturnAfter":-0.0087,"FiveDayReturnBefore":-0.037465},{"Ticker":"PCLN","EffectiveDate":"2015-03-13","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.024296,"FiveDayReturnAfter":-0.0087,"FiveDayReturnBefore":-0.037465},{"Ticker":"PCLN","EffectiveDate":"2015-03-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.024296,"FiveDayReturnAfter":-0.0087,"FiveDayReturnBefore":-0.037465},{"Ticker":"PCLN","EffectiveDate":"2015-03-10","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.02129,"FiveDayReturnAfter":-0.049314,"FiveDayReturnBefore":-0.026274},{"Ticker":"PCLN","EffectiveDate":"2015-03-10","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.02129,"FiveDayReturnAfter":-0.049314,"FiveDayReturnBefore":-0.026274},{"Ticker":"PCLN","EffectiveDate":"2015-03-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.02129,"FiveDayReturnAfter":-0.049314,"FiveDayReturnBefore":-0.026274},{"Ticker":"PCLN","EffectiveDate":"2015-03-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.013172,"FiveDayReturnAfter":-0.041878,"FiveDayReturnBefore":0.018069},{"Ticker":"PCLN","EffectiveDate":"2015-03-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.013172,"FiveDayReturnAfter":-0.041878,"FiveDayReturnBefore":0.018069},{"Ticker":"PCLN","EffectiveDate":"2015-03-03","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.005899,"FiveDayReturnAfter":-0.026274,"FiveDayReturnBefore":0.034045},{"Ticker":"PCLN","EffectiveDate":"2015-03-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.005899,"FiveDayReturnAfter":-0.026274,"FiveDayReturnBefore":0.034045},{"Ticker":"PCLN","EffectiveDate":"2015-03-03","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.005899,"FiveDayReturnAfter":-0.026274,"FiveDayReturnBefore":0.034045},{"Ticker":"PCLN","EffectiveDate":"2015-02-26","Type":"RatingNeutral","Title":"Morgan Stanley initiates coverage on PCLN to Equal-Weight. Target Price is $1300.","DailyReturn":-0.007683,"FiveDayReturnAfter":-0.020344,"FiveDayReturnBefore":0.107837},{"Ticker":"PCLN","EffectiveDate":"2015-02-25","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.025472,"FiveDayReturnAfter":0.018069,"FiveDayReturnBefore":0.084466},{"Ticker":"PCLN","EffectiveDate":"2015-02-25","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.025472,"FiveDayReturnAfter":0.018069,"FiveDayReturnBefore":0.084466},{"Ticker":"PCLN","EffectiveDate":"2015-02-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010111,"FiveDayReturnAfter":0.034045,"FiveDayReturnBefore":0.090249},{"Ticker":"PCLN","EffectiveDate":"2015-02-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010111,"FiveDayReturnAfter":0.034045,"FiveDayReturnBefore":0.090249},{"Ticker":"PCLN","EffectiveDate":"2015-02-24","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.010111,"FiveDayReturnAfter":0.034045,"FiveDayReturnBefore":0.090249},{"Ticker":"PCLN","EffectiveDate":"2015-02-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.010111,"FiveDayReturnAfter":0.034045,"FiveDayReturnBefore":0.090249},{"Ticker":"PCLN","EffectiveDate":"2015-02-20","Type":"RatingNeutral","Title":"Ascendiant Capital maintains PCLN from Buy. Target Price is $1400; previously $1500.","DailyReturn":-0.001494,"FiveDayReturnAfter":0.018868,"FiveDayReturnBefore":0.138924},{"Ticker":"PCLN","EffectiveDate":"2015-02-20","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1425; previously $1375.","DailyReturn":-0.001494,"FiveDayReturnAfter":0.018868,"FiveDayReturnBefore":0.138924},{"Ticker":"PCLN","EffectiveDate":"2015-02-20","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Market Outperform. Target Price is $1375; previously $1230.","DailyReturn":-0.001494,"FiveDayReturnAfter":0.018868,"FiveDayReturnBefore":0.138924},{"Ticker":"PCLN","EffectiveDate":"2015-02-19","Type":"RatingNeutral","Title":"RBC Capital maintains PCLN to Outperform. Target Price is $1450; previously $1300.","DailyReturn":0.084649,"FiveDayReturnAfter":0.107837,"FiveDayReturnBefore":0.059972},{"Ticker":"PCLN","EffectiveDate":"2015-02-19","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.084649,"FiveDayReturnAfter":0.107837,"FiveDayReturnBefore":0.059972},{"Ticker":"PCLN","EffectiveDate":"2015-02-19","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.084649,"FiveDayReturnAfter":0.107837,"FiveDayReturnBefore":0.059972},{"Ticker":"PCLN","EffectiveDate":"2015-02-18","Type":"RatingNeutral","Title":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1230; previously $1300.","DailyReturn":0.001784,"FiveDayReturnAfter":0.084466,"FiveDayReturnBefore":0.081599},{"Ticker":"PCLN","EffectiveDate":"2015-01-23","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1375; previously $1410.","DailyReturn":-0.011137,"FiveDayReturnAfter":-0.033853,"FiveDayReturnBefore":0.013436},{"Ticker":"PCLN","EffectiveDate":"2015-01-08","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades PCLN from Buy.","DailyReturn":0.012416,"FiveDayReturnAfter":-0.032208,"FiveDayReturnBefore":-0.07133},{"Ticker":"PCLN","EffectiveDate":"2014-12-16","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $1310; previously $1265.","DailyReturn":-0.030409,"FiveDayReturnAfter":0.063521,"FiveDayReturnBefore":-0.051532},{"Ticker":"PCLN","EffectiveDate":"2014-12-15","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.022962,"FiveDayReturnAfter":0.004933,"FiveDayReturnBefore":-0.028557},{"Ticker":"PCLN","EffectiveDate":"2014-12-02","Type":"RatingNeutral","Title":"FBR Capital downgrades PCLN to Market Perform from Outperform. Target Price is $1225.","DailyReturn":-0.012001,"FiveDayReturnAfter":-0.015309,"FiveDayReturnBefore":0.00151},{"Ticker":"PCLN","EffectiveDate":"2014-11-25","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.016403,"FiveDayReturnAfter":-0.018074,"FiveDayReturnBefore":-0.005389},{"Ticker":"PCLN","EffectiveDate":"2014-11-24","Type":"RatingNeutral","Title":"Credit Suisse assumes PCLN to Outperform. Target Price is $1450.","DailyReturn":0.007538,"FiveDayReturnAfter":0.00151,"FiveDayReturnBefore":-0.018499},{"Ticker":"PCLN","EffectiveDate":"2014-11-14","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1350; previously $1500.","DailyReturn":0.004238,"FiveDayReturnAfter":-0.012171,"FiveDayReturnBefore":0.06204},{"Ticker":"PCLN","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1410; previously $1460.","DailyReturn":-0.00215,"FiveDayReturnAfter":0.061529,"FiveDayReturnBefore":-0.052284},{"Ticker":"PCLN","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"FBR Capital maintains PCLN to Outperform. Target Price is $1225; previously $1500.","DailyReturn":-0.00215,"FiveDayReturnAfter":0.061529,"FiveDayReturnBefore":-0.052284},{"Ticker":"PCLN","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1500; previously $1545.","DailyReturn":-0.00215,"FiveDayReturnAfter":0.061529,"FiveDayReturnBefore":-0.052284},{"Ticker":"PCLN","EffectiveDate":"2014-11-05","Type":"RatingNeutral","Title":"JMP Securities maintains PCLN to Market Outperform. Target Price is $1300; previously $1450.","DailyReturn":-0.00215,"FiveDayReturnAfter":0.061529,"FiveDayReturnBefore":-0.052284},{"Ticker":"PCLN","EffectiveDate":"2014-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.08412,"FiveDayReturnAfter":-0.067739,"FiveDayReturnBefore":0.055107},{"Ticker":"PCLN","EffectiveDate":"2014-11-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.08412,"FiveDayReturnAfter":-0.067739,"FiveDayReturnBefore":0.055107},{"Ticker":"PCLN","EffectiveDate":"2014-11-04","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1450; previously $1555.","DailyReturn":-0.08412,"FiveDayReturnAfter":-0.067739,"FiveDayReturnBefore":0.055107},{"Ticker":"PCLN","EffectiveDate":"2014-10-30","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1460; previously $1520.","DailyReturn":0.002071,"FiveDayReturnAfter":-0.043657,"FiveDayReturnBefore":0.02636},{"Ticker":"PCLN","EffectiveDate":"2014-10-15","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1550; previously $1600.","DailyReturn":0.007901,"FiveDayReturnAfter":0.075624,"FiveDayReturnBefore":-0.054376},{"Ticker":"PCLN","EffectiveDate":"2014-10-10","Type":"RatingNeutral","Title":"Evercore Partners downgrades PCLN to Hold from Equal-Weight. Target Price is $1250; previously $1350.","DailyReturn":-0.034958,"FiveDayReturnAfter":-0.026664,"FiveDayReturnBefore":-0.03365},{"Ticker":"PCLN","EffectiveDate":"2014-10-10","Type":"RatingNeutral","Title":"Susquehanna maintains PCLN to Positive. Target Price is $1475; previously $1500.","DailyReturn":-0.034958,"FiveDayReturnAfter":-0.026664,"FiveDayReturnBefore":-0.03365},{"Ticker":"PCLN","EffectiveDate":"2014-09-23","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.00048,"FiveDayReturnAfter":-0.004074,"FiveDayReturnBefore":0.010519},{"Ticker":"PCLN","EffectiveDate":"2014-09-23","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00048,"FiveDayReturnAfter":-0.004074,"FiveDayReturnBefore":0.010519},{"Ticker":"PCLN","EffectiveDate":"2014-09-23","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":0.00048,"FiveDayReturnAfter":-0.004074,"FiveDayReturnBefore":0.010519},{"Ticker":"PCLN","EffectiveDate":"2014-09-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.016756,"FiveDayReturnAfter":0.010519,"FiveDayReturnBefore":-0.038493},{"Ticker":"PCLN","EffectiveDate":"2014-09-16","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.016756,"FiveDayReturnAfter":0.010519,"FiveDayReturnBefore":-0.038493},{"Ticker":"PCLN","EffectiveDate":"2014-09-16","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.016756,"FiveDayReturnAfter":0.010519,"FiveDayReturnBefore":-0.038493},{"Ticker":"PCLN","EffectiveDate":"2014-09-16","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.016756,"FiveDayReturnAfter":0.010519,"FiveDayReturnBefore":-0.038493},{"Ticker":"PCLN","EffectiveDate":"2014-09-05","Type":"RatingNeutral","Title":"Evercore Partners downgrades PCLN to Equal-weight from Overweight. Target Price is $1350; previously $1450.","DailyReturn":-0.021085,"FiveDayReturnAfter":-0.036632,"FiveDayReturnBefore":-0.032249},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.00691,"FiveDayReturnAfter":-0.015879,"FiveDayReturnBefore":0.01024},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":-0.00691,"FiveDayReturnAfter":-0.015879,"FiveDayReturnBefore":0.01024},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00691,"FiveDayReturnAfter":-0.015879,"FiveDayReturnBefore":0.01024},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.00691,"FiveDayReturnAfter":-0.015879,"FiveDayReturnBefore":0.01024},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.00691,"FiveDayReturnAfter":-0.015879,"FiveDayReturnBefore":0.01024},{"Ticker":"PCLN","EffectiveDate":"2014-08-14","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.00691,"FiveDayReturnAfter":-0.015879,"FiveDayReturnBefore":0.01024},{"Ticker":"PCLN","EffectiveDate":"2014-08-13","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.000471,"FiveDayReturnAfter":-0.017599,"FiveDayReturnBefore":0.010211},{"Ticker":"PCLN","EffectiveDate":"2014-08-13","Type":"RatingNeutral","Title":"Stifel Nicolaus initiates coverage on PCLN to Buy. Target Price is $1600.","DailyReturn":-0.000471,"FiveDayReturnAfter":-0.017599,"FiveDayReturnBefore":0.010211},{"Ticker":"PCLN","EffectiveDate":"2014-08-13","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.000471,"FiveDayReturnAfter":-0.017599,"FiveDayReturnBefore":0.010211},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1545; previously $1500.","DailyReturn":-0.011396,"FiveDayReturnAfter":-0.025606,"FiveDayReturnBefore":0.007174},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1520; previously $1300.","DailyReturn":-0.011396,"FiveDayReturnAfter":-0.025606,"FiveDayReturnBefore":0.007174},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Pacific Crest maintains PCLN to Outperform. Target Price is $1565; previously $1475.","DailyReturn":-0.011396,"FiveDayReturnAfter":-0.025606,"FiveDayReturnBefore":0.007174},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Macquarie maintains PCLN to Outperform. Target Price is $1595; previously $1500.","DailyReturn":-0.011396,"FiveDayReturnAfter":-0.025606,"FiveDayReturnBefore":0.007174},{"Ticker":"PCLN","EffectiveDate":"2014-08-12","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1600; previously $1500.","DailyReturn":-0.011396,"FiveDayReturnAfter":-0.025606,"FiveDayReturnBefore":0.007174},{"Ticker":"PCLN","EffectiveDate":"2014-08-11","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.02163,"FiveDayReturnAfter":-0.008967,"FiveDayReturnBefore":0.028219},{"Ticker":"PCLN","EffectiveDate":"2014-08-11","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.02163,"FiveDayReturnAfter":-0.008967,"FiveDayReturnBefore":0.028219},{"Ticker":"PCLN","EffectiveDate":"2014-08-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.0005,"FiveDayReturnAfter":0.010211,"FiveDayReturnBefore":0.027376},{"Ticker":"PCLN","EffectiveDate":"2014-08-06","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.0005,"FiveDayReturnAfter":0.010211,"FiveDayReturnBefore":0.027376},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":-0.001574,"FiveDayReturnAfter":0.013847,"FiveDayReturnBefore":0.012208},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.001574,"FiveDayReturnAfter":0.013847,"FiveDayReturnBefore":0.012208},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":-0.001574,"FiveDayReturnAfter":0.013847,"FiveDayReturnBefore":0.012208},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.001574,"FiveDayReturnAfter":0.013847,"FiveDayReturnBefore":0.012208},{"Ticker":"PCLN","EffectiveDate":"2014-07-24","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.001574,"FiveDayReturnAfter":0.013847,"FiveDayReturnBefore":0.012208},{"Ticker":"PCLN","EffectiveDate":"2014-07-18","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.009498,"FiveDayReturnAfter":0.029009,"FiveDayReturnBefore":-0.012212},{"Ticker":"PCLN","EffectiveDate":"2014-07-18","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.009498,"FiveDayReturnAfter":0.029009,"FiveDayReturnBefore":-0.012212},{"Ticker":"PCLN","EffectiveDate":"2014-06-30","Type":"RatingNeutral","Title":"Oppenheimer initiates coverage on PCLN to Outperform. Target Price is $1450.","DailyReturn":-0.002049,"FiveDayReturnAfter":0.038192,"FiveDayReturnBefore":0.00191},{"Ticker":"PCLN","EffectiveDate":"2014-06-27","Type":"RatingNeutral","Title":"Buckingham Research initiates coverage on PCLN to Neutral. Target Price is $1400.","DailyReturn":-0.010044,"FiveDayReturnAfter":0.02066,"FiveDayReturnBefore":0.008967},{"Ticker":"PCLN","EffectiveDate":"2014-06-12","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.018195,"FiveDayReturnAfter":-0.025829,"FiveDayReturnBefore":0.002204},{"Ticker":"PCLN","EffectiveDate":"2014-06-12","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.018195,"FiveDayReturnAfter":-0.025829,"FiveDayReturnBefore":0.002204},{"Ticker":"PCLN","EffectiveDate":"2014-06-12","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.018195,"FiveDayReturnAfter":-0.025829,"FiveDayReturnBefore":0.002204},{"Ticker":"PCLN","EffectiveDate":"2014-06-12","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.018195,"FiveDayReturnAfter":-0.025829,"FiveDayReturnBefore":0.002204},{"Ticker":"PCLN","EffectiveDate":"2014-06-05","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.001597,"FiveDayReturnAfter":0.002204,"FiveDayReturnBefore":-0.019117},{"Ticker":"PCLN","EffectiveDate":"2014-05-09","Type":"RatingNeutral","Title":"UBS maintains PCLN to Buy. Target Price is $1500; previously $1480.","DailyReturn":0.02519,"FiveDayReturnAfter":0.025178,"FiveDayReturnBefore":-0.063466},{"Ticker":"PCLN","EffectiveDate":"2014-05-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.020977,"FiveDayReturnAfter":0.012356,"FiveDayReturnBefore":-0.022721},{"Ticker":"PCLN","EffectiveDate":"2014-05-08","Type":"RatingUpgrade","Title":"Raymond James upgrades PCLN to Strong Buy from Outperform.","DailyReturn":-0.020977,"FiveDayReturnAfter":0.012356,"FiveDayReturnBefore":-0.022721},{"Ticker":"PCLN","EffectiveDate":"2014-05-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":-0.020977,"FiveDayReturnAfter":0.012356,"FiveDayReturnBefore":-0.022721},{"Ticker":"PCLN","EffectiveDate":"2014-04-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.049904,"FiveDayReturnAfter":-0.018767,"FiveDayReturnBefore":-0.029791},{"Ticker":"PCLN","EffectiveDate":"2014-04-01","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.049904,"FiveDayReturnAfter":-0.018767,"FiveDayReturnBefore":-0.029791},{"Ticker":"PCLN","EffectiveDate":"2014-03-04","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.022477,"FiveDayReturnAfter":0.003878,"FiveDayReturnBefore":0.01853},{"Ticker":"PCLN","EffectiveDate":"2014-03-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.022477,"FiveDayReturnAfter":0.003878,"FiveDayReturnBefore":0.01853},{"Ticker":"PCLN","EffectiveDate":"2014-02-21","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $1400; previously $1300.","DailyReturn":0.025448,"FiveDayReturnAfter":0.056658,"FiveDayReturnBefore":0.028748},{"Ticker":"PCLN","EffectiveDate":"2014-02-21","Type":"RatingNeutral","Title":"Macquarie maintains PCLN to Outperform. Target Price is $1500; previously $1380.","DailyReturn":0.025448,"FiveDayReturnAfter":0.056658,"FiveDayReturnBefore":0.028748},{"Ticker":"PCLN","EffectiveDate":"2014-02-21","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1450; previously $1320.","DailyReturn":0.025448,"FiveDayReturnAfter":0.056658,"FiveDayReturnBefore":0.028748},{"Ticker":"PCLN","EffectiveDate":"2014-02-20","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.007254,"FiveDayReturnAfter":0.06326,"FiveDayReturnBefore":0.048109},{"Ticker":"PCLN","EffectiveDate":"2014-02-20","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.007254,"FiveDayReturnAfter":0.06326,"FiveDayReturnBefore":0.048109},{"Ticker":"PCLN","EffectiveDate":"2014-02-20","Type":"RatingNeutral","Title":"Oracle Investment Research initiates coverage on PCLN to Strong Buy. Target Price is $1400.","DailyReturn":0.007254,"FiveDayReturnAfter":0.06326,"FiveDayReturnBefore":0.048109},{"Ticker":"PCLN","EffectiveDate":"2014-02-19","Type":"RatingNeutral","Title":"Monness Crespi Hardt maintains PCLN to Buy. Target Price is $1500; previously $1250.","DailyReturn":-0.021419,"FiveDayReturnAfter":0.039062,"FiveDayReturnBefore":0.074807},{"Ticker":"PCLN","EffectiveDate":"2014-02-13","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $1450; previously $1275.","DailyReturn":0.023607,"FiveDayReturnAfter":0.028748,"FiveDayReturnBefore":0.103549},{"Ticker":"PCLN","EffectiveDate":"2014-01-07","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1320; previously $1210.","DailyReturn":0.020658,"FiveDayReturnAfter":0.000167,"FiveDayReturnBefore":-0.026653},{"Ticker":"PCLN","EffectiveDate":"2013-12-05","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.006161,"FiveDayReturnAfter":-0.003017,"FiveDayReturnBefore":0.003129},{"Ticker":"PCLN","EffectiveDate":"2013-11-26","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.016227,"FiveDayReturnAfter":0.014824,"FiveDayReturnBefore":0.027319},{"Ticker":"PCLN","EffectiveDate":"2013-11-20","Type":"RatingUpgrade","Title":"Goldman Sachs upgrades PCLN to Conviction Buy from Buy. Target Price is $1500; previously $1260.","DailyReturn":0.025634,"FiveDayReturnAfter":0.051883,"FiveDayReturnBefore":0.01707},{"Ticker":"PCLN","EffectiveDate":"2013-11-08","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $1200; previously $1100.","DailyReturn":0.049184,"FiveDayReturnAfter":0.106148,"FiveDayReturnBefore":-0.0298},{"Ticker":"PCLN","EffectiveDate":"2013-11-08","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1250; previously $1200.","DailyReturn":0.049184,"FiveDayReturnAfter":0.106148,"FiveDayReturnBefore":-0.0298},{"Ticker":"PCLN","EffectiveDate":"2013-11-08","Type":"RatingUpgrade","Title":"Monness, Crespi, Hardt upgrades PCLN to Buy from Neutral.","DailyReturn":0.049184,"FiveDayReturnAfter":0.106148,"FiveDayReturnBefore":-0.0298},{"Ticker":"PCLN","EffectiveDate":"2013-11-08","Type":"RatingUpgrade","Title":"Monness Crespi Hardt upgrades PCLN to Buy from Neutral. Target Price is $1250.","DailyReturn":0.049184,"FiveDayReturnAfter":0.106148,"FiveDayReturnBefore":-0.0298},{"Ticker":"PCLN","EffectiveDate":"2013-11-07","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.033222,"FiveDayReturnAfter":0.060654,"FiveDayReturnBefore":-0.009886},{"Ticker":"PCLN","EffectiveDate":"2013-11-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.033222,"FiveDayReturnAfter":0.060654,"FiveDayReturnBefore":-0.009886},{"Ticker":"PCLN","EffectiveDate":"2013-11-07","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2013 Q3's earning $17.33 per share and revenue $2269MM. This beats analyst's estimated EPS $16.21, beats estimated revenue $2210MM.","DailyReturn":-0.033222,"FiveDayReturnAfter":0.060654,"FiveDayReturnBefore":-0.009886},{"Ticker":"PCLN","EffectiveDate":"2013-11-05","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $1220; previously $1060.","DailyReturn":0.010891,"FiveDayReturnAfter":0.023932,"FiveDayReturnBefore":0.00978},{"Ticker":"PCLN","EffectiveDate":"2013-11-05","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1150.","DailyReturn":0.010891,"FiveDayReturnAfter":0.023932,"FiveDayReturnBefore":0.00978},{"Ticker":"PCLN","EffectiveDate":"2013-11-04","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.017169,"FiveDayReturnAfter":0.019476,"FiveDayReturnBefore":-0.017285},{"Ticker":"PCLN","EffectiveDate":"2013-11-04","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.017169,"FiveDayReturnAfter":0.019476,"FiveDayReturnBefore":-0.017285},{"Ticker":"PCLN","EffectiveDate":"2013-11-04","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":0.017169,"FiveDayReturnAfter":0.019476,"FiveDayReturnBefore":-0.017285},{"Ticker":"PCLN","EffectiveDate":"2013-10-23","Type":"RatingNeutral","Title":"FBR Capital initiates coverage on PCLN to Outperform. Target Price is $1250.","DailyReturn":-0.008981,"FiveDayReturnAfter":-0.005697,"FiveDayReturnBefore":0.051625},{"Ticker":"PCLN","EffectiveDate":"2013-10-22","Type":"RatingNeutral","Title":"Credit Suisse assumes PCLN to Outperform. Target Price is $1250.","DailyReturn":-0.010542,"FiveDayReturnAfter":-0.025094,"FiveDayReturnBefore":0.066029},{"Ticker":"PCLN","EffectiveDate":"2013-10-21","Type":"RatingNeutral","Title":"Susquehanna maintains PCLN to Positive. Target Price is $1200; previously $1135.","DailyReturn":0.037052,"FiveDayReturnAfter":0.02133,"FiveDayReturnBefore":0.036549},{"Ticker":"PCLN","EffectiveDate":"2013-09-12","Type":"RatingNeutral","Title":"Janney Capital initiates coverage on PCLN to Neutral. Target Price is $925.","DailyReturn":-0.011991,"FiveDayReturnAfter":0.013692,"FiveDayReturnBefore":0.030104},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $1130; previously $1040.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $1050; previously $900.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $1100; previously $800.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $1150; previously $1010.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $1060; previously $940.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $1130; previously $1005.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $1100; previously $1034.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $1120; previously $980.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Buy. Target Price is $1200; previously $985.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-09","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1200; previously $1025.","DailyReturn":0.038704,"FiveDayReturnAfter":0.005383,"FiveDayReturnBefore":0.031992},{"Ticker":"PCLN","EffectiveDate":"2013-08-08","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2013 Q2's earning $9.7 per share and revenue $1680MM. This beats analyst's estimated EPS $9.38, beats estimated revenue $1660MM.","DailyReturn":0.006652,"FiveDayReturnAfter":0.013301,"FiveDayReturnBefore":0.057589},{"Ticker":"PCLN","EffectiveDate":"2013-08-08","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.006652,"FiveDayReturnAfter":0.013301,"FiveDayReturnBefore":0.057589},{"Ticker":"PCLN","EffectiveDate":"2013-08-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.006652,"FiveDayReturnAfter":0.013301,"FiveDayReturnBefore":0.057589},{"Ticker":"PCLN","EffectiveDate":"2013-08-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.007323,"FiveDayReturnAfter":0.031212,"FiveDayReturnBefore":0.044561},{"Ticker":"PCLN","EffectiveDate":"2013-08-06","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":0.007323,"FiveDayReturnAfter":0.031212,"FiveDayReturnBefore":0.044561},{"Ticker":"PCLN","EffectiveDate":"2013-08-01","Type":"RatingNeutral","Title":"Bank of America maintains PCLN to Buy. Target Price is $940; previously $925.","DailyReturn":0.032752,"FiveDayReturnAfter":0.057589,"FiveDayReturnBefore":-0.020739},{"Ticker":"PCLN","EffectiveDate":"2013-07-30","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $1034; previously $850.","DailyReturn":-0.001407,"FiveDayReturnAfter":0.044561,"FiveDayReturnBefore":-0.013833},{"Ticker":"PCLN","EffectiveDate":"2013-07-24","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $1025; previously $860.","DailyReturn":-0.001976,"FiveDayReturnAfter":-0.010019,"FiveDayReturnBefore":-0.006964},{"Ticker":"PCLN","EffectiveDate":"2013-07-10","Type":"RatingNeutral","Title":"Susquehanna initiates coverage on PCLN to Positive. Target Price is $1080.","DailyReturn":-0.005284,"FiveDayReturnAfter":0.005549,"FiveDayReturnBefore":0.064853},{"Ticker":"PCLN","EffectiveDate":"2013-07-08","Type":"RatingUpgrade","Title":"Morgan Stanley upgrades PCLN to Overweight from Equal-Weight. Target Price is $1010; previously $760.","DailyReturn":0.039139,"FiveDayReturnAfter":0.07351,"FiveDayReturnBefore":0.039075},{"Ticker":"PCLN","EffectiveDate":"2013-06-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.013074,"FiveDayReturnAfter":0.015468,"FiveDayReturnBefore":0.004071},{"Ticker":"PCLN","EffectiveDate":"2013-06-06","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.013074,"FiveDayReturnAfter":0.015468,"FiveDayReturnBefore":0.004071},{"Ticker":"PCLN","EffectiveDate":"2013-06-06","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":0.013074,"FiveDayReturnAfter":0.015468,"FiveDayReturnBefore":0.004071},{"Ticker":"PCLN","EffectiveDate":"2013-05-30","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.019274,"FiveDayReturnAfter":0.004071,"FiveDayReturnBefore":-0.041644},{"Ticker":"PCLN","EffectiveDate":"2013-05-30","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.019274,"FiveDayReturnAfter":0.004071,"FiveDayReturnBefore":-0.041644},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":-0.014994,"FiveDayReturnAfter":-0.007035,"FiveDayReturnBefore":-0.046363},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.014994,"FiveDayReturnAfter":-0.007035,"FiveDayReturnBefore":-0.046363},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.014994,"FiveDayReturnAfter":-0.007035,"FiveDayReturnBefore":-0.046363},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":-0.014994,"FiveDayReturnAfter":-0.007035,"FiveDayReturnBefore":-0.046363},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_2.03","Title":"Issue new debts or other obligations.\r\n","DailyReturn":-0.014994,"FiveDayReturnAfter":-0.007035,"FiveDayReturnBefore":-0.046363},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"RatingNeutral","Title":"Lazard maintains PCLN to Buy. Target Price is $950; previously $859.","DailyReturn":-0.014994,"FiveDayReturnAfter":-0.007035,"FiveDayReturnBefore":-0.046363},{"Ticker":"PCLN","EffectiveDate":"2013-05-29","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.014994,"FiveDayReturnAfter":-0.007035,"FiveDayReturnBefore":-0.046363},{"Ticker":"PCLN","EffectiveDate":"2013-05-21","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.019632,"FiveDayReturnAfter":-0.046363,"FiveDayReturnBefore":0.080368},{"Ticker":"PCLN","EffectiveDate":"2013-05-21","Type":"Item_2.01","Title":"Completion of Acquisition or Disposition of Assets\r\n","DailyReturn":-0.019632,"FiveDayReturnAfter":-0.046363,"FiveDayReturnBefore":0.080368},{"Ticker":"PCLN","EffectiveDate":"2013-05-21","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.019632,"FiveDayReturnAfter":-0.046363,"FiveDayReturnBefore":0.080368},{"Ticker":"PCLN","EffectiveDate":"2013-05-20","Type":"RatingUpgrade","Title":"Deutsche Bank upgrades PCLN to Buy from Hold. Target Price is $900; previously $715.","DailyReturn":0.035445,"FiveDayReturnAfter":-0.015531,"FiveDayReturnBefore":0.061132},{"Ticker":"PCLN","EffectiveDate":"2013-05-09","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.003033,"FiveDayReturnAfter":0.091536,"FiveDayReturnBefore":0.05768},{"Ticker":"PCLN","EffectiveDate":"2013-05-09","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2013 Q1's earning $5.76 per share and revenue $1300MM. This beats analyst's estimated EPS $5.27, beats estimated revenue $1280MM.","DailyReturn":0.003033,"FiveDayReturnAfter":0.091536,"FiveDayReturnBefore":0.05768},{"Ticker":"PCLN","EffectiveDate":"2013-05-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.003033,"FiveDayReturnAfter":0.091536,"FiveDayReturnBefore":0.05768},{"Ticker":"PCLN","EffectiveDate":"2013-04-02","Type":"RatingNeutral","Title":"UBS initiates coverage on PCLN to Buy. Target Price is $825.","DailyReturn":0.014588,"FiveDayReturnAfter":0.001106,"FiveDayReturnBefore":-0.003085},{"Ticker":"PCLN","EffectiveDate":"2013-03-21","Type":"RatingNeutral","Title":"Evercore Partners assumes PCLN to Overweight. Target Price is $850.","DailyReturn":-0.005221,"FiveDayReturnAfter":0.010533,"FiveDayReturnBefore":-0.039845},{"Ticker":"PCLN","EffectiveDate":"2013-03-19","Type":"RatingNeutral","Title":"JMP Securities initiates coverage on PCLN to Market Outperform. Target Price is $850.","DailyReturn":-0.018168,"FiveDayReturnAfter":-0.00168,"FiveDayReturnBefore":-0.039756},{"Ticker":"PCLN","EffectiveDate":"2013-03-01","Type":"RatingUpgrade","Title":"Lazard upgrades PCLN to Buy from Neutral.","DailyReturn":0.009447,"FiveDayReturnAfter":0.042503,"FiveDayReturnBefore":0.008424},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Cantor Fitzgerald maintains PCLN to Buy. Target Price is $800; previously $750.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Ascendiant Capital maintains PCLN to Buy. Target Price is $875; previously $870.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $820; previously $780.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Buy. Target Price is $825; previously $770.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $895; previously $847.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $835; previously $740.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Stifel Nicolaus maintains PCLN to Buy. Target Price is $860; previously $760.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Hold. Target Price is $745; previously $710.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-27","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $800; previously $756.","DailyReturn":0.025675,"FiveDayReturnAfter":0.057172,"FiveDayReturnBefore":-0.036155},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"EarningBeat","Title":"After market close, PCLN reports 2012 Q4's earning $6.77 per share and revenue $1190MM. This beats analyst's estimated EPS $6.54, meets estimated revenue $1190MM.","DailyReturn":0.010349,"FiveDayReturnAfter":0.061325,"FiveDayReturnBefore":-0.044729},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.010349,"FiveDayReturnAfter":0.061325,"FiveDayReturnBefore":-0.044729},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.010349,"FiveDayReturnAfter":0.061325,"FiveDayReturnBefore":-0.044729},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.010349,"FiveDayReturnAfter":0.061325,"FiveDayReturnBefore":-0.044729},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010349,"FiveDayReturnAfter":0.061325,"FiveDayReturnBefore":-0.044729},{"Ticker":"PCLN","EffectiveDate":"2013-02-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.010349,"FiveDayReturnAfter":0.061325,"FiveDayReturnBefore":-0.044729},{"Ticker":"PCLN","EffectiveDate":"2013-02-22","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.002005,"FiveDayReturnAfter":0.008424,"FiveDayReturnBefore":-0.030041},{"Ticker":"PCLN","EffectiveDate":"2013-02-22","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.002005,"FiveDayReturnAfter":0.008424,"FiveDayReturnBefore":-0.030041},{"Ticker":"PCLN","EffectiveDate":"2013-01-31","Type":"RatingNeutral","Title":"Morgan Stanley downgrades PCLN to Equal-Weight from Overweight. Target Price is $730; previously $750.","DailyReturn":-0.01384,"FiveDayReturnAfter":-0.001426,"FiveDayReturnBefore":0.033396},{"Ticker":"PCLN","EffectiveDate":"2013-01-30","Type":"RatingNeutral","Title":"Ascendiant Capital initiates coverage on PCLN to Buy. Target Price is $870.","DailyReturn":-0.007425,"FiveDayReturnAfter":-0.01253,"FiveDayReturnBefore":0.042323},{"Ticker":"PCLN","EffectiveDate":"2013-01-29","Type":"RatingNeutral","Title":"Ascendiant initiates coverage on PCLN to Buy. Target Price is $870.","DailyReturn":-0.006653,"FiveDayReturnAfter":-0.037122,"FiveDayReturnBefore":0.046841},{"Ticker":"PCLN","EffectiveDate":"2013-01-25","Type":"RatingNeutral","Title":"Nomura maintains PCLN to Buy. Target Price is $820; previously $730.","DailyReturn":0.057788,"FiveDayReturnAfter":0.008673,"FiveDayReturnBefore":0.017384},{"Ticker":"PCLN","EffectiveDate":"2013-01-03","Type":"RatingUpgrade","Title":"Bank of America upgrades PCLN to Buy from Neutral. Target Price is $770; previously $690.","DailyReturn":0.016181,"FiveDayReturnAfter":0.02045,"FiveDayReturnBefore":0.033546},{"Ticker":"PCLN","EffectiveDate":"2013-01-03","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":0.016181,"FiveDayReturnAfter":0.02045,"FiveDayReturnBefore":0.033546},{"Ticker":"PCLN","EffectiveDate":"2013-01-03","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.016181,"FiveDayReturnAfter":0.02045,"FiveDayReturnBefore":0.033546},{"Ticker":"PCLN","EffectiveDate":"2012-12-12","Type":"RatingNeutral","Title":"Janney Capital initiates coverage on PCLN to Neutral. Target Price is $650.","DailyReturn":0.002423,"FiveDayReturnAfter":0.015161,"FiveDayReturnBefore":-0.063096},{"Ticker":"PCLN","EffectiveDate":"2012-12-10","Type":"RatingNeutral","Title":"Deutsche Bank downgrades PCLN to Hold from Buy. Target Price is $710; previously $800.","DailyReturn":-0.050281,"FiveDayReturnAfter":-0.07163,"FiveDayReturnBefore":-0.006186},{"Ticker":"PCLN","EffectiveDate":"2012-12-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.050281,"FiveDayReturnAfter":-0.07163,"FiveDayReturnBefore":-0.006186},{"Ticker":"PCLN","EffectiveDate":"2012-12-10","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.050281,"FiveDayReturnAfter":-0.07163,"FiveDayReturnBefore":-0.006186},{"Ticker":"PCLN","EffectiveDate":"2012-12-07","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.007589,"FiveDayReturnAfter":-0.079998,"FiveDayReturnBefore":-0.002405},{"Ticker":"PCLN","EffectiveDate":"2012-11-21","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.006293,"FiveDayReturnAfter":0.034742,"FiveDayReturnBefore":0.008327},{"Ticker":"PCLN","EffectiveDate":"2012-11-20","Type":"RatingNeutral","Title":"JG Capital initiates coverage on PCLN to Overweight. Target Price is $780.","DailyReturn":0.016115,"FiveDayReturnAfter":0.017825,"FiveDayReturnBefore":-0.012598},{"Ticker":"PCLN","EffectiveDate":"2012-11-08","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":-0.010621,"FiveDayReturnAfter":-0.029114,"FiveDayReturnBefore":0.100781},{"Ticker":"PCLN","EffectiveDate":"2012-11-08","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.010621,"FiveDayReturnAfter":-0.029114,"FiveDayReturnBefore":0.100781},{"Ticker":"PCLN","EffectiveDate":"2012-11-02","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $800; previously $750.","DailyReturn":0.082989,"FiveDayReturnAfter":0.068842,"FiveDayReturnBefore":0.029539},{"Ticker":"PCLN","EffectiveDate":"2012-11-02","Type":"RatingUpgrade","Title":"Stifel Nicolaus upgrades PCLN to Buy from Hold. Target Price is $760.","DailyReturn":0.082989,"FiveDayReturnAfter":0.068842,"FiveDayReturnBefore":0.029539},{"Ticker":"PCLN","EffectiveDate":"2012-11-02","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $838; previously $806.","DailyReturn":0.082989,"FiveDayReturnAfter":0.068842,"FiveDayReturnBefore":0.029539},{"Ticker":"PCLN","EffectiveDate":"2012-11-02","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $780; previously $740.","DailyReturn":0.082989,"FiveDayReturnAfter":0.068842,"FiveDayReturnBefore":0.029539},{"Ticker":"PCLN","EffectiveDate":"2012-11-01","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.021489,"FiveDayReturnAfter":0.100781,"FiveDayReturnBefore":0.011517},{"Ticker":"PCLN","EffectiveDate":"2012-11-01","Type":"EarningsRevenueBeat","Title":"After market close, PCLN reports 2012 Q3's earning $12.4 per share and revenue $1700MM. This beats analyst's estimated EPS $11.81, beats estimated revenue $1650MM.","DailyReturn":0.021489,"FiveDayReturnAfter":0.100781,"FiveDayReturnBefore":0.011517},{"Ticker":"PCLN","EffectiveDate":"2012-11-01","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.021489,"FiveDayReturnAfter":0.100781,"FiveDayReturnBefore":0.011517},{"Ticker":"PCLN","EffectiveDate":"2012-11-01","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.021489,"FiveDayReturnAfter":0.100781,"FiveDayReturnBefore":0.011517},{"Ticker":"PCLN","EffectiveDate":"2012-10-17","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $806; previously $727.","DailyReturn":0.000786,"FiveDayReturnAfter":-0.049255,"FiveDayReturnBefore":-0.033104},{"Ticker":"PCLN","EffectiveDate":"2012-10-10","Type":"Item_5.02","Title":"Change of exectives and board members.\r\n","DailyReturn":-0.025053,"FiveDayReturnAfter":-0.033104,"FiveDayReturnBefore":0.002609},{"Ticker":"PCLN","EffectiveDate":"2012-10-10","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.025053,"FiveDayReturnAfter":-0.033104,"FiveDayReturnBefore":0.002609},{"Ticker":"PCLN","EffectiveDate":"2012-09-21","Type":"RatingNeutral","Title":"Cantor Fitzgerald initiates coverage on PCLN to Buy. Target Price is $740.","DailyReturn":0.003755,"FiveDayReturnAfter":-0.005142,"FiveDayReturnBefore":0.010852},{"Ticker":"PCLN","EffectiveDate":"2012-09-07","Type":"RatingUpgrade","Title":"Nomura upgrades PCLN to Buy from Neutral. Target Price is $700; previously $740.","DailyReturn":0.029056,"FiveDayReturnAfter":0.037261,"FiveDayReturnBefore":0.001309},{"Ticker":"PCLN","EffectiveDate":"2012-09-04","Type":"RatingNeutral","Title":"Jefferies assumes PCLN to Buy. Target Price is $740; previously $695.","DailyReturn":-0.012703,"FiveDayReturnAfter":0.006184,"FiveDayReturnBefore":0.01902},{"Ticker":"PCLN","EffectiveDate":"2012-08-17","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.003391,"FiveDayReturnAfter":0.01142,"FiveDayReturnBefore":0.042703},{"Ticker":"PCLN","EffectiveDate":"2012-08-09","Type":"RatingNeutral","Title":"Lazard downgrades PCLN to Neutral.","DailyReturn":-0.000107,"FiveDayReturnAfter":0.022838,"FiveDayReturnBefore":-0.134043},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Barclays maintains PCLN to Overweight. Target Price is $725; previously $800.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $725; previously $840.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Citigroup maintains PCLN to Buy. Target Price is $740; previously $850.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Buy. Target Price is $760; previously $860.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $710; previously $780.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $650; previously $770.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $727; previously $820.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $675; previously $811.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Deutsche Bank maintains PCLN to Buy. Target Price is $675; previously $713.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Monness Crespi Hardt downgrades PCLN to Neutral from Buy.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Bank of America downgrades PCLN to Neutral from Buy. Target Price is $615; previously $790.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-08","Type":"RatingNeutral","Title":"Stifel Nicolaus downgrades PCLN to Hold from Buy.","DailyReturn":-0.172816,"FiveDayReturnAfter":-0.185575,"FiveDayReturnBefore":0.026925},{"Ticker":"PCLN","EffectiveDate":"2012-08-07","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.022071,"FiveDayReturnAfter":-0.168466,"FiveDayReturnBefore":-0.025854},{"Ticker":"PCLN","EffectiveDate":"2012-08-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.022071,"FiveDayReturnAfter":-0.168466,"FiveDayReturnBefore":-0.025854},{"Ticker":"PCLN","EffectiveDate":"2012-08-07","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.022071,"FiveDayReturnAfter":-0.168466,"FiveDayReturnBefore":-0.025854},{"Ticker":"PCLN","EffectiveDate":"2012-08-07","Type":"EarningsBeatRevenueMiss","Title":"PCLN reports 2012 Q2's earning $7.85 per share and revenue $1330MM. This beats analyst's estimated EPS $7.37, misses estimated revenue $1350MM.","DailyReturn":0.022071,"FiveDayReturnAfter":-0.168466,"FiveDayReturnBefore":-0.025854},{"Ticker":"PCLN","EffectiveDate":"2012-07-31","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.030474,"FiveDayReturnAfter":-0.025854,"FiveDayReturnBefore":0.019872},{"Ticker":"PCLN","EffectiveDate":"2012-07-19","Type":"RatingNeutral","Title":"Credit Suisse maintains PCLN to Outperform. Target Price is $822; previously $820.","DailyReturn":0.025912,"FiveDayReturnAfter":-0.038305,"FiveDayReturnBefore":0.013853},{"Ticker":"PCLN","EffectiveDate":"2012-06-07","Type":"Item_5.07","Title":"Submission of Matters to a Vote of Security Holders\r\n","DailyReturn":-0.009899,"FiveDayReturnAfter":0.00619,"FiveDayReturnBefore":0.00742},{"Ticker":"PCLN","EffectiveDate":"2012-06-06","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $770; previously $810.","DailyReturn":0.036591,"FiveDayReturnAfter":0.042869,"FiveDayReturnBefore":-0.059821},{"Ticker":"PCLN","EffectiveDate":"2012-05-09","Type":"EarningsRelease","Title":"After market close, PCLN reports 2012 Q1's earning $3.54 per share and revenue $1037MM..","DailyReturn":0.00384,"FiveDayReturnAfter":-0.078194,"FiveDayReturnBefore":-0.052982},{"Ticker":"PCLN","EffectiveDate":"2012-05-09","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.00384,"FiveDayReturnAfter":-0.078194,"FiveDayReturnBefore":-0.052982},{"Ticker":"PCLN","EffectiveDate":"2012-05-09","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.00384,"FiveDayReturnAfter":-0.078194,"FiveDayReturnBefore":-0.052982},{"Ticker":"PCLN","EffectiveDate":"2012-05-09","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.00384,"FiveDayReturnAfter":-0.078194,"FiveDayReturnBefore":-0.052982},{"Ticker":"PCLN","EffectiveDate":"2012-05-07","Type":"RatingNeutral","Title":"JP Morgan maintains PCLN to Overweight. Target Price is $810; previously $730.","DailyReturn":0.002147,"FiveDayReturnAfter":-0.086033,"FiveDayReturnBefore":-0.034791},{"Ticker":"PCLN","EffectiveDate":"2012-04-27","Type":"RatingNeutral","Title":"Bank oferica maintains PCLN to Buy. Target Price is $800; previously $740.","DailyReturn":0.039358,"FiveDayReturnAfter":0.0222,"FiveDayReturnBefore":0.022188},{"Ticker":"PCLN","EffectiveDate":"2012-04-11","Type":"RatingNeutral","Title":"Goldman Sachs maintains PCLN to Buy. Target Price is $875; previously $700.","DailyReturn":-0.01577,"FiveDayReturnAfter":-0.035551,"FiveDayReturnBefore":0.029141},{"Ticker":"PCLN","EffectiveDate":"2012-04-11","Type":"RatingNeutral","Title":"Benchmark maintains PCLN to Buy. Target Price is $840; previously $692.","DailyReturn":-0.01577,"FiveDayReturnAfter":-0.035551,"FiveDayReturnBefore":0.029141},{"Ticker":"PCLN","EffectiveDate":"2012-04-10","Type":"RatingNeutral","Title":"Cowen & Co. initiates coverage on PCLN to Outperform.","DailyReturn":-0.030716,"FiveDayReturnAfter":-0.085616,"FiveDayReturnBefore":0.063775},{"Ticker":"PCLN","EffectiveDate":"2012-03-26","Type":"Item_5.03","Title":"Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year\r\n","DailyReturn":0.028546,"FiveDayReturnAfter":0.003504,"FiveDayReturnBefore":0.056815},{"Ticker":"PCLN","EffectiveDate":"2012-03-26","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.028546,"FiveDayReturnAfter":0.003504,"FiveDayReturnBefore":0.056815},{"Ticker":"PCLN","EffectiveDate":"2012-03-22","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $763; previously $727.","DailyReturn":0.011852,"FiveDayReturnAfter":0.020466,"FiveDayReturnBefore":0.078154},{"Ticker":"PCLN","EffectiveDate":"2012-03-16","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $775; previously $725.","DailyReturn":0.027767,"FiveDayReturnAfter":0.079998,"FiveDayReturnBefore":0.005231},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_3.02","Title":"Unregistered Sales of Equity Securities\r\n","DailyReturn":0.018833,"FiveDayReturnAfter":0.037479,"FiveDayReturnBefore":-0.004783},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.018833,"FiveDayReturnAfter":0.037479,"FiveDayReturnBefore":-0.004783},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_1.01","Title":"Entry into a Material Definitive Agreement\r\n","DailyReturn":0.018833,"FiveDayReturnAfter":0.037479,"FiveDayReturnBefore":-0.004783},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.018833,"FiveDayReturnAfter":0.037479,"FiveDayReturnBefore":-0.004783},{"Ticker":"PCLN","EffectiveDate":"2012-03-07","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":0.018833,"FiveDayReturnAfter":0.037479,"FiveDayReturnBefore":-0.004783},{"Ticker":"PCLN","EffectiveDate":"2012-03-06","Type":"Item_8.01","Title":"Other 8-K Events\r\n","DailyReturn":-0.02015,"FiveDayReturnAfter":0.012769,"FiveDayReturnBefore":0.082935},{"Ticker":"PCLN","EffectiveDate":"2012-03-06","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":-0.02015,"FiveDayReturnAfter":0.012769,"FiveDayReturnBefore":0.082935},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Jefferies maintains PCLN to Buy. Target Price is $695; previously $590.","DailyReturn":0.069683,"FiveDayReturnAfter":0.082935,"FiveDayReturnBefore":0.015366},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"PiperJaffray maintains PCLN to Overweight. Target Price is $727; previously $670.","DailyReturn":0.069683,"FiveDayReturnAfter":0.082935,"FiveDayReturnBefore":0.015366},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Morgan Keegan maintains PCLN to Outperform. Target Price is $730; previously $625.","DailyReturn":0.069683,"FiveDayReturnAfter":0.082935,"FiveDayReturnBefore":0.015366},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Citigroup maintains PCLN to Buy. Target Price is $850; previously $700.","DailyReturn":0.069683,"FiveDayReturnAfter":0.082935,"FiveDayReturnBefore":0.015366},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Evercore Partners maintains PCLN to Equal-Weight. Target Price is $570; previously $540.","DailyReturn":0.069683,"FiveDayReturnAfter":0.082935,"FiveDayReturnBefore":0.015366},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"UBS maintains PCLN to Neutral. Target Price is $680; previously $550.","DailyReturn":0.069683,"FiveDayReturnAfter":0.082935,"FiveDayReturnBefore":0.015366},{"Ticker":"PCLN","EffectiveDate":"2012-02-28","Type":"RatingNeutral","Title":"Morgan Stanley maintains PCLN to Overweight. Target Price is $725; previously $690.","DailyReturn":0.069683,"FiveDayReturnAfter":0.082935,"FiveDayReturnBefore":0.015366},{"Ticker":"PCLN","EffectiveDate":"2012-02-27","Type":"Item_9.01","Title":"Financial Statements and Exhibits\r\n","DailyReturn":0.001914,"FiveDayReturnAfter":0.089767,"FiveDayReturnBefore":0.032868},{"Ticker":"PCLN","EffectiveDate":"2012-02-27","Type":"Item_2.02","Title":"Release results of operational and financial condition\r\n","DailyReturn":0.001914,"FiveDayReturnAfter":0.089767,"FiveDayReturnBefore":0.032868},{"Ticker":"PCLN","EffectiveDate":"2012-02-27","Type":"Item_7.01","Title":"Fair disclosure\r\n","DailyReturn":0.001914,"FiveDayReturnAfter":0.089767,"FiveDayReturnBefore":0.032868}];